As the global healthcare system accelerates its acceptance of gene therapies as one-time, potentially curative, treatment options for rare diseases, the role of patient engagement in informing drug development strategy […]

Advance your end-to-end logistics strategy to deliver vital therapeutics at the RIGHT TIME, RIGHT PLACE and the RIGHT TEMPERATURE Join us in Frankfurt in June 2023 in a brand-new venue at […]

Returning for the 3rd year, the ILD Summit will lean into the industry’s key challenges, explore pipeline opportunity development, and look towards the future for ILD therapeutic development from idiopathic pulmonary fibrosis pipelines. From illuminating predictors […]

With exciting developments in pioneering inhaled drug products from Moderna, Vertex, ReCode Therapeutics, and Pieris Pharmaceuticals, now is the time to go full speed ahead on your efforts into inhaled formulation and […]

Exciting results are expected this year, from multiple mid and late stage clinical trials and involving a broad array of adenosine drugs including CD73, CD39 and A2AR! To ensure the […]

This event will take place in London on 21-22 June 2023 in London, focusing on the three biggest priorities enabling growth in the AMR field - Innovation, Investment & Policy […]

As the biggest industry-led meeting on novel vector development, the 3rd Annual Next Generation Gene Therapy Vectors Summit (June 27-29, 2023 | Boston, MA) will bring together 100+ key opinion […]

The 8th Microbiome Movement Drug Development Summit returns in 2023 as North America's definitive microbiome drug development event - and it's back bigger and better than ever! The microbiome-based therapeutic […]

CNS biopharma is rapidly investing in digital technologies to revolutionize clinical identification and monitoring of complex neurological disorders through more objective, frequent, sensitive, and less invasive measures of movement, speech, […]

With more than 300 trials in preclinical and clinical development actively using AAV as their vector of choice, the priority for any company working in this space is to ensure […]

The Advanced Wound Care Summit is wound care’s only industry-led forum It’s a chance for senior executives to address shared challenges around innovative product development, build meaningful partnerships, and sharpen […]

The 3rd Annual Tumor Myeloid-Directed Therapies Summit returns with over 75% new speakers to share insights across a range of myeloid targets, including CD40, CD39, LILRB2, CLEC-1 as well as […]

There is a vast number of ADCs that never make it to the clinic let alone to market, and this is largely due to toxicological challenges providing a narrow therapeutic […]

With the exciting news that Novartis has received US FDA approval for Pluvicto for previously-treated patients with PSMA-positive metastatic castration-resistant prostate cancer, the TRP space is continuing to go from strength to strength. This is why the upcoming 2nd […]

Design & Engineer Functional & Manufacturable Novel Fusion Proteins Prepare to be captivated by the Fusion Protein Engineering & Developability Summit, the ultimate event tailored to drug developers with groundbreaking […]

Established industry leaders and emerging innovators such as Adicet Bio, IN8Bio, Sanofi, Merck, LAVA Therapeutics, Takeda and Leucid Bio are driving the race to demonstrate the potential of Gamma Delta […]

The 3rd mRNA-Based Therapeutics Summit returns to Boston this July, cementing its position as the world’s only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines. Download the event program here. […]

Investments in linker and conjugation technologies have become the single-biggest area of investments within the ADC field, showing how they are being used as key levers for ADC drug developers […]

Bringing together technical experts from biopharma and academia, the brand-new RNA Assay Development & Screening Summit has been curated to support in-house assay development and screening strategies to find new RNA targets, and ultimately […]

Last year was momentous for the cell therapy field: it was the year that CAR-T therapies became CURATIVE. This decade of success has resulted in explosive investment into the development of […]

Rapid development and rising demand of oligonucleotide drugs is fuelling revolutionary steps in biopharma investment and technology advancement for pipeline progression. The prospect of defining impurities and suitable CQAs for […]

The development of next-generation drug-based approaches to treat inner ear disorders is gaining momentum, with multiple INDs approved in the last six months and big pharma making plays to acquire […]

The 5th Exosome Based Therapeutic Development Summit returns with a refreshed program, with data-driven insights from those pioneering the field who are dedicated to the clinical translation and commercialization of […]

The 4th Annual Gene Therapy Immunogenicity Summit is your opportunity to connect with likeminded peers from gene therapy drug developers, along with leading academics, regulators, and key service providers, all […]

The hotly anticipated 13th World Clinical Biomarkers & CDx Summit returns as the only industry-led meeting uniting 600+ senior decision makers in the biomarker and CDx field to accelerate clinically […]

With the recent FDA approval of SYFOVRE and more decisions and approvals expected in 2023, the Complement-Based Drug Development Summit is returning for its 7th year in a timely fashion. Be the first to view this […]

Fingerprinting Your LNP Drug Product Quality, Safety, Efficacy & Regulatory Compliance With the recent breakthroughs from Verve Therapeutics, Vertex-Arbor Bio, and Mana.bio propelling the field of LNP technology forward at lightning speed beyond mRNA […]

Your one-stop shop to capturing industry’s most exciting developments to tackle rare & genetic kidney diseases. From evaluating real-world outcomes to uncovering underlying pathophysiology to interrogating translational models, the 3rd […]

Wearable Injectors and Connected Devices USA Conference: September, 13 – 14 2023 Boston, USA Website: http://www.wearableinjectors-usa.com/PharmaJournalist-EL Advancing digital health and on-body drug delivery devices for enhanced patient experience Following the […]

FIbroGen’s recent Phase 3 trial failure for pamrevlumab exemplifies the critical time point the pulmonary fibrosis field is currently at as drug developers move through in-human to Phase 2 to […]